We need your help to achieve the goal of growing our online, geographically searchable database of resources and support for cancer patients, their families and caregivers. Whether you're in the initial phase of shock, in the battle, or handling the aftermath of cancer, our resources take out the stress of searching multiple places and thousands of online listings.
The preauricular lymph nodes sit just in front of the ears. Some medical problems, such as infections, can cause them to swell. Learn more here.
When health conditions cause a buildup of lymph fluid, people can use lymphatic drainage massage to get this fluid moving. In this article, we discuss the benefits of lymphatic massage and how to do it at home.
R-CHOP chemotherapy uses a combination of five different drugs to treat specific types of cancer, including non-Hodgkin lymphoma. Learn more about how this treatment works and the potential side effects here.
The symptoms, treatment, and survival rates of stage 4 lymphoma depend on the type of lymphoma and the risk factors that the individual has. Learn more here.
Hepatitis C is a viral infection with different treatment options. Medication, treatments, and care pricing depend on factors that include a person’s insurance policy and their overall health. There are various medications available. Learn more about the costs of hepatitis C treatment here.
Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. Although doctors can very rarely cure CLL, survival rates for this cancer are typically good. A person’s life expectancy for CLL depends on how far the cancer has progressed and when they receive treatment. Learn more here.
When the cells in the blood do not function as they should, it is possible a person has a blood disorder. Examples include leukemia, lymphoma, and myeloma. Common blood disorder symptoms include unexplained exhaustion and weight loss. Learn more about the types of blood disorder and the signs to look out for here.
The discovery of tri-specific natural killer engagers (TriKE™), a combination protein that bridges an immune cell and a tumor cell to drive tumor cell killing power exponentially, has led to a new Phase I, first-in-human study to treat leukemia.
A $5 million gift from the Edward P. Evans Foundation will create the Edward P. Evans Center for Myelodysplastic Syndromes at Dana-Farber Cancer Institute.
An estimated 61,780 new cases of leukemia will be diagnosed in the United States this year, with some 2,000 cases in New Jersey, according to the American Cancer Society.
Cancer cells form tumors. This statement, simple as it seems, hides a complex failure of normal immune responses that should eliminate tumor cells from the body before they ever form viable cancer masses.
Acute myeloid leukemia stem cells elude the body's immune cells by deactivating a danger detector. The underlying mechanisms and the potential new therapeutic approaches that this gives rise to have been detailed in the journal Nature by researchers from the University of Basel and University Hospital Basel in collaboration with colleagues in Germany.
Patients with chronic myeloid leukemia can be treated with tyrosine kinase inhibitors. While these effective drugs lead to deep remission and prolonged survival, primitive leukemia stem cells resist elimination during the remission and persist as a major barrier to cure.
A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute "Cancer Moonshot" grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia.